CONSENSUS WIRE

What Other Sources Are Reporting

Not consensus-verified. Every item below is carried only by outlets republishing finished copy. Nothing first-hand or secondhand corroborates it, so these reports do not meet the bar for a Consensus Wire article. Treat them as leads to check, not as confirmed reporting.

AI·573 items
Financial·Reported by 3 outside sources·

Shareholders considered resolutions regarding auditor, board size, corporate name rebrand to Helus Pharma, and director elections at an Annual General and Special Meeting.

Who
Cybin Inc. shareholders and board
Where
United States
When
Why
unknown
via marketaux
Financial·Reported by 3 outside sources·

GameStop disclosed a $4.9 billion stake in eBay while facing expiration of 59 million warrants.

Who
GameStop Corp., eBay Inc.
Where
United States
When
Why
GameStop is attempting a major retail comeback deal with eBay, potentially contingent on stock price thresholds.
via marketaux
Financial·Reported by 5 outside sources·

Analysts at Melius Research issued a Street-high price target of $2,200 for Micron Technology stock, implying over 110% upside, while other peers like Western Digital and Seagate show lower implied upside.

Who
Micron Technology, Inc. (MU) and Melius Research
Where
United States
When
Why
Micron's high-bandwidth memory (HBM) chips are critical to AI hardware, with multi-year contracts providing revenue visibility and supply-demand tightness expected to persist beyond 2027.
via marketaux
Financial·Reported by 5 outside sources·

published an article recommending three cybersecurity stocks for investment.

Who
The Motley Fool
Where
United States
When
Why
to provide investment recommendations and promote Stock Advisor service
via marketaux
Financial·Reported by 5 outside sources·

The Motley Fool published an article promoting the Vanguard U.S. Value Factor ETF as an investment option for investors concerned about AI valuations.

Who
The Motley Fool
Where
United States
When
Why
To encourage investors to consider value stocks over growth stocks and AI-related tech stocks, citing Vanguard research and historical performance data.
via marketaux
Financial·Reported by 5 outside sources·

The Motley Fool published an article analyzing Nebius Group (NBIS) as a high-growth AI stock with potential for significant returns by 2027.

Who
The Motley Fool analysts and Keithen Drury
Where
United States
When
Why
To promote investment in Nebius Group and highlight its growth potential compared to other AI stocks.
via marketaux
Financial·Reported by 4 outside sources·

Insiders at four quantum computing companies have sold over $895 million in shares while buying almost none, raising concerns about stock valuations despite strong recent performance.

Who
The Motley Fool analysts and insiders of IonQ, Rigetti Computing, D-Wave Quantum, and Quantum Computing Inc.
Where
United States (Wall Street/NYSE/NASDAQ)
When
Why
Insiders are selling shares primarily for tax liability and diversification, while lack of insider buying suggests limited expectation of share appreciation.
via marketaux
Financial·Reported by 3 outside sources·

Lloyds Banking Group outlined its strategy for growth, investment and efficiency through 2030 while noting U.K. consumer resilience.

Who
Charlie Nunn, chief executive of Lloyds Banking Group
Where
United Kingdom
When
Why
to outline the bank's strategy for growth, investment and efficiency through 2030
via marketaux
Financial·Reported by 3 outside sources·

PureTech Health outlined progress across its portfolio in its 2026 half-year results call.

Who
PureTech Health plc
When
Why
unknown
via marketaux
Financial·Reported by 3 outside sources·

Stellantis N.V. is increasing investments in its European manufacturing operations to enhance capacity and efficiency while targeting €6 billion in annual savings by 2028.

Who
Stellantis N.V.
Where
Europe (France, Spain)
When
Why
To boost growth and profitability, compete effectively in electric and hybrid segments, address overcapacity, and respond to pressure from cheaper Chinese brands.
via marketaux
Financial·Reported by 3 outside sources·

The FDA approved Fayuvi for treating neurologic manifestations of Sanfilippo syndrome Type A in pediatric patients with preserved neurodevelopmental function.

Who
Ultragenyx Pharmaceutical Inc.
Where
United States
When
Why
To provide a treatment for Sanfilippo syndrome Type A in pediatric patients with preserved neurodevelopmental function.
via marketaux
Financial·Reported by 3 outside sources·

The Motley Fool published an article comparing AbbVie and Pfizer as dividend stock investment options for September.

Who
The Motley Fool
Where
United States (implied by NYSE tickers)
When
Why
To recommend AbbVie as a better dividend stock buy than Pfizer based on its dividend growth history and financial strength.
via marketaux
Financial·Reported by 6 outside sources·

A prediction is made that AST SpaceMobile will be the best-performing space stock of 2027 due to its scaling satellite network and upcoming beta service.

Who
AST SpaceMobile, Inc.
Where
United States
When
Why
The bull case for AST SpaceMobile's stock performance in 2027 is based on its scaling satellite network, upcoming beta service, and partnership with Japan.
via marketaux
Financial·Reported by 7 outside sources·

Wells Fargo raised its price target for Meta Platforms Inc to $796 ahead of Connect.

Who
Wells Fargo, Meta Platforms Inc
Where
United States
When
Why
buyers are betting on Muse usage numbers the company has not yet disclosed and that this week's developer event will either validate or crush
via marketaux
Financial·Reported by 7 outside sources·

24/7 Wall St. analysts issued a buy rating and $426 price target for Broadcom stock despite it not making their top 10 stocks list, citing strong AI revenue growth.

Who
Broadcom Inc., 24/7 Wall St.
Where
United States
When
Why
Broadcom's fiscal Q3 2026 results showed AI semiconductor revenue surged 221% year-over-year, while shares remained relatively flat.
via marketaux
Financial·Reported by 7 outside sources·

released its second-quarter 2026 investor letter for the Carillon Eagle Small Cap Growth Fund highlighting Black Rock Coffee Bar, Inc.

Who
Carillon Tower Advisers
Where
United States
When
Why
to provide investment analysis and performance updates on small-cap stocks including Black Rock Coffee Bar, Inc.
via marketaux
Financial·Reported by 7 outside sources·

released its Q2 2026 investor letter for the Sustainable Value Strategy and highlighted Methanex Corporation as a detractor due to geopolitical risk premium unwinding and operational setbacks.

Who
Riverwater Partners
Where
United States (NASDAQ)
When
Why
Methanex Corporation detracted from performance due to the unwinding of a geopolitical risk premium related to the Iran/Hormuz conflict and an operational setback involving the idling of its Titan methanol plant.
via marketaux
Financial·Reported by 12 outside sources·

Analysts at The Motley Fool argue that Nike is the most durable stock among three consumer names (Nike, On Holding, Deckers Outdoor) despite recent declines due to Federal Reserve interest rate hikes.

Who
The Motley Fool analysts and investors
Where
United States (NYSE listed companies)
When
Why
Nike's deep brand equity and habit-based demand are expected to withstand higher borrowing costs better than growth-focused competitors like On Holding and Deckers Outdoor.
via marketaux
Financial·Reported by 8 outside sources·

sold 3,913 shares of common stock on Sept. 14, 2026, with the overall position increasing due to a simultaneous restricted stock award vesting.

Who
Clay M. Gaspar, President and CEO of Devon Energy Corporation
Where
United States
When
Why
unknown
via marketaux
Financial·Reported by 7 outside sources·

SpaceX stock (SPCX) experienced significant market volatility and valuation changes following its June 2026 IPO and ahead of the September 28, 2026 Starship orbital launch attempt.

Who
SpaceX, Coinbase, Yahoo Finance, Benzinga, TechCrunch, Morgan Stanley, Peter Schiff, Pivotal Research Group, Mizuho Securities
Where
United States (Nasdaq)
When
Why
Market dynamics driven by thin public float, passive index fund flows from Nasdaq-100 inclusion, and anticipation of the Flight 14 orbital insertion mission.
via marketaux
Financial·Reported by 7 outside sources·

Major U.S. stock market indexes rallied on Monday as oil prices retreated and chip stocks surged, driven by positive sentiment around AI developments and geopolitical discussions.

Who
The Motley Fool, Wall Street investors, major stock market indexes (Nasdaq Composite, S&P 500, Dow Jones Industrial Average), oil companies (Aramco), technology companies (Meta Platforms, Advanced Micro Devices, Intel, NVIDIA)
Where
United States
When
Why
Oil prices fell due to supply concerns from Saudi Arabia, which lifted pressure on Treasury bonds and allowed technology stocks to rise; additionally, positive AI developments and upcoming geopolitical meetings influenced market sentiment.
via marketaux
Financial·Reported by 9 outside sources·

The article discusses market downturns, AI investment opportunities, and Warren Buffett's advice on buying stocks during bear markets.

Who
The Motley Fool analysts and Warren Buffett
Where
United States
When
Why
To encourage investors to buy quality stocks during market downturns and consider specific stock recommendations from The Motley Fool Stock Advisor.
via marketaux
Financial·Reported by 8 outside sources·

Old Dominion Freight Line announced a 4.9% general rate increase effective October 5.

Who
Old Dominion Freight Line
Where
United States
When
Why
LTL carriers are accelerating rate hikes
via marketaux
Financial·Reported by 9 outside sources·

An article predicts that two specific Vanguard ETFs could be excellent long-term investment choices.

Who
marketaux / finance.yahoo.com
Where
United States
When
Why
The article cites diversification, low fees, and strong long-term growth potential as reasons for the prediction.
via marketaux
Financial·Reported by 6 outside sources·

The company announced it is targeting a valuation of up to $1.74 billion for its US IPO.

Who
ADARx Pharmaceuticals
Where
United States
When
Why
to join a wave of biotech companies planning for a US IPO
via marketaux